Contact this trialFirst, we need to learn more about you.
Insulin
Insulin Lispro (U100) +1 More for Type 2 Diabetes
Recruiting3 awardsPhase 3
Greenville, North Carolina
This trial will compare the safety and effectiveness of a new diabetes drug, tirzepatide, to the current standard of care, insulin lispro. The trial is for people with type 2 diabetes who are already taking insulin glargine (U100) with or without metformin.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.